FILTER
FILTERED INTERVIEW RESULTS
Ivan Doku
PRINCIPAL RESOURCE GEOLOGIST AND GHANA COUNTRY MANAGER, SRK CONSULTING
"Buoyant commodity prices have certainly boosted the mining sector in West Africa, leading to better demand for technical studies, audits, reviews and other work that SRK offers."
Caigen Wang
CEO TIETTO MINERALS
"The main challenge Tietto faces today is to reinvent ourselves from junior explorers to mining operators of a reasonably large open pit mine and processing system."
Douglas MacQuarrie
PRESIDENT & CEO, ASANTE GOLD
"We are helped by the high gold prices and a market keen to provide the needed capital to wake up this sleeping giant."
Dolores Biamou
MINING PROJECTS DIRECTOR AFRICA, BOLLORÉ LOGISTICS
Bolloré Logistics explains how it has been able to maintain the supply chain for mines in Africa despite the pandemic and security threats.
Michael White
PRESIDENT AND CEO, IBK CAPITAL
IBK Capital outlines the current trends in mining investments.
Laurent Piat
MANAGING DIRECTOR, VEOLIA GHANA
Veolia designs and provides solutions for water, waste and energy management.
Bernard Kaninda
REGIONAL DIRECTOR AFRICA, MAXAM
Maxam describes its services and the current opportunities in West Africa.
Deon de Kock
PRESIDENT, SUB-SAHARAN AFRICA, MIDDLE EAST & SOUTH ASIA, FLSMIDTH
FLSmidth is an international supplier of sustainable solutions and services to the global cement and mining industries.
Mxolisi Mgojo, Nombasa Tsengwa & Sakkie Swanepoel
CEO; CEO-DESIGNATE AND MANAGING DIRECTOR OF MINERALS & GROUP MANAGER MARKETING, EXXARO RESOURCES
Exxaro considers the role of coal as South Africa moves towards green energies.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
